XML 33 R21.htm IDEA: XBRL DOCUMENT
v3.20.4

FAIR VALUE OF FINANCIAL INSTRUMENTS | 9 Months Ended
--- | ---
Dec. 31, 2020
Fair Value Disclosures [Abstract] |
Fair Value Disclosures [Text Block] | NOTE 16 – FAIR VALUE OF FINANCIAL INSTRUMENTS As of December 31, 2020, the Company’s marketable securities consist of liquid funds, which have been classified as Level 1 of the fair value hierarchy because they have been valued using quoted prices in active markets. The decrease in value of marketable securities is due to realization of approximately $3.1 million and increase due to dividend income of approximately $14 thousand and approximately $5 thousand unrealized gain during the nine months ended December 31, 2020. The Company’s cash and cash equivalents have also been classified as Level 1 on the same principle. Financial instruments are classified as current if they are expected to be liquidated within the next twelve months. The Company’s remaining investments have been classified as Level 3 instruments as there is little or no market data. Level 3 investments are valued using cost-method. For further information refer Note 7 – Investments in Non-Marketable Securities. The following table presents information about the Company’s assets that are measured at fair value on a recurring basis as of December 31, 2020 and March 31, 2020, and indicates the fair value hierarchy of the valuation techniques the Company used to determine such fair value: (in thousands)
|  | Level 1 ($) |  |  | Level 2 ($) |  |  | Level 3 ($) |  |  | Total ($) |
December 31, 2020 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents: |  |  | 968 |  |  |  | - |  |  |  | - |  |  |  | 968 |
Total cash and cash equivalents |  |  | 968 |  |  |  | - |  |  |  | - |  |  |  | 968 |
Investments: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
-Marketable securities |  |  | 2,000 |  |  |  | - |  |  |  | - |  |  |  | 2,000 |
-Non-marketable securities |  |  | - |  |  |  | - |  |  |  | 261 |  |  |  | 261 |
Total Investments |  |  | 2,000 |  |  |  | - |  |  |  | 261 |  |  |  | 2,261 |
|  | Level 1 ($) |  |  | Level 2 ($) |  |  | Level 3 ($) |  |  | Total ($) |
March 31, 2020 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents: |  |  | 7,258 |  |  |  | - |  |  |  | - |  |  |  | 7,258 |
Total cash and cash equivalents |  |  | 7,258 |  |  |  | - |  |  |  | - |  |  |  | 7,258 |
Investments: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
-Marketable securities |  |  | 5,081 |  |  |  | - |  |  |  | - |  |  |  | 5,081 |
-Non-marketable securities |  |  | - |  |  |  | - |  |  |  | 11 |  |  |  | 11 |
Total Investment |  |  | 5,081 |  |  |  | - |  |  |  | 11 |  |  |  | 5,092 |

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration